Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 2,700 QNCX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 2,700 | n/a |
| Jan 21, 2026 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 29,423 | n/a |
| Jun 6, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Jan 9, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 47,587 | n/a |
| Jun 8, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Dec 14, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 300 | $300.00 |
| Dec 7, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 19,123 | $19.3K |
| Dec 1, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 14,378 | $14.1K |
| Aug 31, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 41,026 | $53.7K |
| Aug 17, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 107,886 | $142.4K |